Exchange: NYSEArca·Updated 06:57 PM EDT
IHE logo

IHEiShares U.S. Pharmaceuticals ETF

$91.88
$0.95
(1.02%)
Today
Closed $91.88
$0.03
(0.03%)
After Hours
Vol172,827.00
52W High$95.60
52W Low$64.46
News
all
press releases
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.
Zacks
News Placeholder
More News
News Placeholder
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike
Healthcare ETFs are gaining attention as Middle East tensions and market volatility boost demand for defensive sectors.
Zacks
News Placeholder
Healthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B Bet
LLY's $4B vaccine push is boosting interest in healthcare ETFs like IHE with heavy exposure to the drugmaker.
Zacks
News Placeholder
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics
ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care.
Zacks
News Placeholder
REPL, QURE Stocks Rise Amid Makary’s Reported Resignation As FDA Chief
The New York Times reported that Makary’s departure was driven in large part by his strong opposition to the administration’s decision to authorize fruit-flavored e-cigarettes.
Stocktwits
News Placeholder
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Sector ETF report for IHE
Zacks
News Placeholder
Trump Slaps 100% Tariffs On Imported Patented Drugs, Sparing Companies That Onshore Or Cut Prices
The new levies apply to patented drugs made in countries with which the U.S. have no tariff deals and by companies that haven’t inked drug pricing deals with the administration.
Stocktwits
News Placeholder
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report
Pharmaceutical companies can avoid these tariffs if they move their manufacturing to the U.S. or are currently negotiating a deal with the Trump administration.
Stocktwits
News Placeholder
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move
Eli Lilly's $2.75B AI drug deal with Insilico spotlights healthcare ETFs as investors seek diversified exposure to the fast-growing AI-driven pharma space.
Zacks
News Placeholder
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
Sector ETF report for IHE
Zacks
<
1
2
...
>

Advertisement|Remove ads.